| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 339 | 245 | 1.970 | 215 | 63 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 339 | 245 | 1.970 | 215 | 63 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 254 | 42 | 26 | 0 | 0 | 0 | 0 | 0 | 157 | - |
| Gross Profit/Loss - EUR | 85 | 203 | 1.944 | 215 | 63 | 0 | 0 | 0 | -157 | - |
| Net Profit/Loss - EUR | 75 | 196 | 1.885 | 208 | 61 | 0 | 0 | 0 | -157 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Vicos Med 2017 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 50 | 49 | 49 | 48 | 47 | 46 | 45 | 45 | 0 | - |
| Current Assets | 596 | 533 | 524 | 569 | 558 | 548 | 535 | 537 | 423 | - |
| Inventories | 471 | 466 | 458 | 450 | 441 | 433 | 423 | 424 | 423 | - |
| Receivables | 125 | 67 | 65 | 119 | 117 | 115 | 112 | 113 | 0 | - |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Shareholders Funds | -2.352 | -2.132 | -211 | 1 | 63 | 61 | 60 | 60 | -97 | - |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | - |
| Debts | 2.998 | 2.714 | 783 | 616 | 542 | 532 | 520 | 522 | 520 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
5520
|
|||||||||
Comments - Vicos Med 2017 Srl